curriculum vitae - Scuola Superiore Sant`Anna

Transcript

curriculum vitae - Scuola Superiore Sant`Anna
LEOPOLDO TRIESTE
Contact
Information
Personal data
Last Update: July 18, 2016
Business Addresses
Residence
Scuola Superiore Sant’Anna
10, p.zza Bastreri
Institute of Management,
Porto Venere, SP, 19025
33, p.zza Martiri della Libertà
Pisa, PI, 56127
19, via la Maddalena,
+39 050 883816
Pisa, PI, 56125
+39 338 8477889
[email protected]
http://www.santannapisa.it/it/personale/leopoldo-trieste
Date of birth: March 29, 1980
Nationality: Italian
Research
Interests
Management, health economics, HTA, innovation diffusion, decision models and simulation
in health economic evaluation.
Education
Specialization courses
DES Simulation for Economic Analyses I-II
Milan (IT), ISPOR. Advisors: J. Jaime Caro, Jörgen Möller
Nov. 9, 2015
Management of No-profit Clinical Trials
Genoa (IT), CISEF, Gaslini Institute.
Jan. 29, 2015
Bayesian Analysis and application in Health Economics
Nov 9, 2014
Amsterdam (NL), ISPOR. Advisors: Christopher S. Hollenbeak, Keith R. Abrams.
Economic Evaluation of Health Care Programmes
July 17-19, 2014
Turin (IT), SIFO. Advisors: Michael F. Drummond, Mark Sculpher, and Andrea
Manca.
Clinical trial in Pediatrics and for Rare Diseases
Dec. 18-20, 2013
Genoa (IT), CISEF, Gaslini Institute. Advisors: Ornella della Casa Alberighi,
Romano Arcieri.
Philosophy of technology
Milan, Bocconi University. Advisor: Emanuele Severino
Nov. 2001 - June 2002
University education
Ph.D. Management, Competitiveness and Development
2007 - 2010
Scuola Superiore Sant’Anna, Pisa (IT)
Topic: Economic implications of market deregulation. The Italian OtC retail market
Advisors: Giuseppe Turchetti and Riccardo Varaldo. Final score: 100/100 magna
cum laude.
M.Sc. Management of Innovation
Scuola Superiore Sant’Anna, Pisa (IT)
Topic: Scenario analysis for future business.
Advisor: Andrea Piccaluga.
2004 - 2005
B.A. Economics, Statistics and Social Science
Bocconi University, Milan (IT)
Thesis: Bayesian and non Bayesian updating in decision making
Advisor: Aldo Montesano, Fabio Maccheroni
1999 - 2004
1 of 8
Current
Position
Post Doc researcher
Institute of Management, Scuola Superiore Sant’Anna
Researcher
IN-SAT Lab, Scuola Superiore Sant’Anna
Advisor: Riccardo Varaldo
Researcher
CRF-BIT, FIAT Research Center
Advisor: Paolo Dindo
Partecipation in
National and
International
projects
2010 to present
2006 - 2010
2005
RACE
2016-2018
Regional project (Tuscany) on the development of an economic decision support
system for the real time assessment and simulation of the cost-effectiveness of alternative
treatments and patients’ follow-up.
Implementation of Chronic Care Model
2014-2016
Implementation of Chronic Care Model using Tele-care and Home care, in patients
with multiple comorbidities: evaluation of the cost-effectiveness and quality of life
(Funded by Italian Ministry of Health; code RF-2011-02350801) - 2014-2017. The
principal aim is to develop Health Care management models (i.e. CCM) supported
by the use of low cost Tele-care tools (telemonitoring with registration of clinical
data on the GPs Electronic Health Records). The second aim is to assess the impact
of Tele-care on quality of care, health related QoL, costs and equity of access to
healthcare services on community living disabled elderly people with chronic health
conditions.
Robot-Era
2012-2015
RobotEra Project (FP7-288899). Project title: Implementation and integration
of advanced Robotic systems and intelligent Environments in real scenarios for
Ageing population: specific attention is devoted to the evaluation and the assessment
(effectiveness, cost-effectiveness and quality of life) of novel technologies developed
in the project, in a Health Technology Assessment (HTA) perspective.
Impact
2012-2014
HTA and analysis of the clinical decision making changes of portable ultrasounds
for general practitioners. Scuola Superiore Sant’Anna, Pisa University, Esaote s.p.a.
Radicea
2011-2015
Radices Project, No. 40-41800-98-007 ERA-NET PrioMedchild: New drugs for
rare diseases: cost-effectiveness modellng in cryopyrin associated periodic syndromes
(CAPS). Project sponsored by AIFA - Agenzia italiana per il Farmaco (I), and ANR
- Agency Nationale de la Recerche (F).
Past projects
- Analisi di impatto e strategie di valorizzazione
2008-2010
dell’insediamento Alenia Composite, Scuola Superiore Sant’Anna, Finmeccanica,
Alenia Aeronautica, Boeing.
- L’erogazione in farmacia di servizi
2008
integrati con il SSR. Analisi dell?impatto economico - organizzativo. Scuola
Superiore Sant’Anna, U.R.TO.FAR.
2 of 8
- Gli Scenari di sviluppo della G.D.O. nel mercato O.T.C.
2006
Scuola Superiore Sant’Anna, Pisa, Parma University, Boeringher-Ingelheim;
Institutional
positions
Vice President of the ISPOR student chapter
Treasurer of the SPOR student chapter at Scuola Sant’Anna
Representative of the IDM Post-Doc Researchers
Instutue of Management council, Scuola Superiore Sant’Anna.
from 2015
2013 - 2015
from 2014
Representative of the PhD-Students
2008-2009
in Economics and Management, Council of the Sant’Anna School of Advanced Study,
Social Science Class.
Teaching
Experience
Challenges and Constraints in Producing,
July 14 2016
Assessing and Transferring the Value of Assistive Robotics
1st International Summer School in Regulation of Robotics in Europe: Legal, Ethical
and Economic Implications.
Scuola Superiore Sant’Anna
Valutazione economiche: concetti e modelli
per i programmi di telemedicina
Sapienza University of Rome.
May 2016
Management of Innovation
from 2014
Module Coordinator (PhD. course, in English), Pisa University
Faculty of Information Engineering and TeCiP, Scuola Superiore Sant’Anna
Models and methods for Health Economic evaluation
Pisa University, Medicine and Biomedical Engineering Faculties
Economic Evaluation of Health Care Programmes
Master: ”Smart Solutions - Smart Communities (SSSC)”.
Scuola Superiore Sant’Anna
Theory of clinical decision making
Pisa University, Faculty of Biomedical Engineering
from 2014
November 2014
from 2012
The Monti decree: future scenarios: bad and good strategies Spring 2009
SIAF International School for Advanced Education
New governance and the pharmacy network
SIAF International School for Advanced Education
Spring 2008
The economic impacts of new services in pharmacy Nov. 2007 - April 2008
SIAF International School for Advanced Education
Marketing, market and business; Firm strategies
Fabrica 136-Pon-Tech
Refereed
Journal
Publications
Feb.-March 2007
1. Tagliente, I., Solvoll, T., Trieste, L., De Cecco, C., Murgia, F., Bella, S. Which
indicators for measuring the daily physical activity? An overview on the challenges
and technology limits for telehealth applications. Journal of Technology and
3 of 8
Health Care 2016: 1: 1-8.
2. Tagliente, I., Trieste, L., Solvoll, T., Murgia, F., Bella, S. Telemonitoring in
Cystic Fibrosis: A 4-year Assessment and Simulation for the Next 6 Years Interact
J Med Res 2016; 5(2): e11.
3. Salvini, P., Bertolini, A., Pagliai, T., Morachioli, A., Acerbi, G., Trieste, L.,
Cavallo, F., Turchetti, G., Dario, P. On robots and insurance. Inter. J. of Social
Robotics 2016.
4. Triulzi, I., Trieste, L., Belli, C., Pani, M. Turchetti, G. 2016. Development
of an Objective Feedback score for the evaluation of drug and medical device
manufacturers/distributors as an additional parameter to be considered in public
procurement. Eur J Hosp Pharm 2016;23(Suppl 1): A115.
5. Trieste, L., Della Casa Alberighi O, Turchetti G, Pierotti F, Accame L, Lorenzoni
V, Frenkel J, Gattorno M, Quartier P,, Martini A. An in Silico Health economic
model applied to Cryopyrin Associated period syndromes (CAPS): cost effectiveness
of prevention effects of ultra-orphan drugs for rare diseases. Value in Health 2015;
18(7): A669.
6. Cavallo, F., Trieste, L., Esposito, R., Aquilano, M., Dario, P., Turchetti, G. Are
the elderly citizens ready for assisted living technologies? An Italian case Study.
Value in Health 2015; 18(7): A514.
7. Trieste, L., Della Casa Alberighi O, Turchetti G, Pierotti F, Accame L, Lorenzoni
V, Frenkel J, Gattorno M, Quartier P,, Martini A. Cost-effectiveness analysis and
prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied
to Cryopyrin Associated Periodic Syndromes (CAPS). Pediatric Rheumatology
2015; 13(Suppl 1):P186.
8. Turchetti, G., Kroes, M., Lorenzoni, V., Trieste, L., Chapman, A., Wilson, G.,s
Sweet, A.C, Neglia, D. The cost-effectiveness of diagnostic cardiac imaging for
stable coronary artery disease. Expert Review of Pharmacoeconomics & Outcomes
Research 2015; 31:1-9.
9. Trieste, L., Della Casa Alberighi O, Turchetti G, Pierotti F, Accame L, Lorenzoni
V, Frenkel J, Gattorno M, Quartier P,, Martini A. Cost-effectiveness analysis and
prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied
to Cryopyrin Associated Periodic Syndromes (CAPS). Poster accepted at ISSAID
2015: 8th International Congress of Familial Mediterranean Fever and Systemic
Autoinflammatory Diseases. Pediatric Rheumatology 2015; 13(Suppl 1):P185.
10. Lorenzoni, V., Trieste, L., Turchetti, G. The cost effectiveness of drug therapies to
treat secondary hyperparathyroidism in renal failure: a focus on evidence about
paricalcitol and cinacalcet. Expert Review of Pharmacoeconomics & Outcomes
Research 2015; 17:1-14.
11. Pierotti, F., Trieste, L., Turchetti, G. Different Strategies for Latent TB Assessment
in Patients Undergoing Anti-TNF Treatment: an Economic Model. Value in
Health, 2014; 17(7):, A551.
12. Gialetti, S., Trieste, L., Pierotti, F., Turchetti, G., Silvestri, M., Della Casa
Alberighi, O. Comparison of Generic, Condition-Specific and Mapped Health State
Utility Values for Pediatric Asthma. Value in Health 2014; 17(7): A552.
13. Turchetti, G., Vitiello N., Trieste L., Romiti, S., Geisler E., Micera, S. 2014. Why
effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence
its adoption? IEEE Reviews in Biomedical Engineering 7: 143-153.
4 of 8
14. Trieste, L., Turchetti, G. 2014. Cost for TB care in developed countries: which
data for an economic evaluation? Journal of Rheumatology 05/2014; 91:83-85.
15. Trieste, L., Palla, I., Fusco, F., Tani, C., Baldini, C., Mosca, M., Turchetti, G.
2012. The economic impact of gout: a systematic literature review. Clinical and
Experimental Rheumatology 30: S145-148.
16. Trieste, L., Palla, I., Baldini, C., Talarico, R., D’Angiolella, L., Mosca, M.,
Turchetti, G. 2012. Systemic vasculitis: how little we know about their societal
and economic burden. Clinical and Experimental Rheumatology 30: S154-156.
17. Palla, I., Trieste, L., Tani, C., Talarico, R., Cortesi, M., Mosca M., Turchetti,
G. 2012. A systematic literature review of the economic impact of ankylosing
spondylitis. Clinical and Experimental Rheumatology 30: S136-141.
18. Turchetti, G., Pierotti, F., Palla, I., Trieste, L. 2012. The definition of a
new organizational, technology-based, integrated home care model. International
Journal Of Computer Assisted Radiology And Surgery 7: S480: S481.
Books
Contributes in
Volume
Katiranta, A., Kulvik, M. Maijanen, S., Tahvanainen, A., Trieste, L., Turchetti,
G., Tähitnen, M. 2015. Raiders of lost value. Helsinki: Taloustieto Oy. ISBN
978-951-628-632-0.
1. Belli, C., Trieste, L., Triulzi, I. 2016. La misurazione e la valutazione del
fornitore/fornitura La Farmacologistica 2, Edizioni il Campano, forthcoming.
2. Turchetti, G., Trieste, L. 2014. Innovazione tecnologica, dinamica del contesto
economico e logistica in sanità, in La Farmacologistica, Edizioni il Campano: Pisa.
ISBN 978-8-67528-247-2.
3. Turchetti, G., Cannizzo, S. and Trieste, L. 2012 Natural and man-made disasters:
challenges and international outlooks for insurance, in De Guttry, A., Gestri, M,
and Venturini, G. (eds.), International Disaster Response Law, Asser TMC series,
Springer Verlag. ISBN 978-90-6704-881-1.
Conferences
1. Triulzi, I., Trieste, L., Belli, C., Pani, M. Turchetti, G. 2016. Development
of an Objetive Feedback score for the evaluation of drug and medical device
manufacturers/distributors as an additional parameter to be considered in public
procurement. 21st Congress of the EAHP. Wien, 16-18th March 2016.
2. Trieste, L. China-Italy potential collaboration for research and consulting activities
in economics and management of healthcare services. China - Italy Science,
Technology & Innovation Week, Beijing (China), November 16-17, 2015.
3. Trieste, L. Organization and government of Healthcare systems: policy and
managerial perspectives. China - Italy Science, Technology & Innovation Week,
Chongqing (China), November 19, 2015.
4. Trieste, L. Economic evaluation of new biomedical technologies for a sustainable
healthcare: market potential analysis, pharmaco-economics and HTA tools. China
- Italy Science, Technology & Innovation Week, Chongqing (China), November 20,
2015.
5. Trieste, L., Della Casa Alberighi O, Turchetti G, Pierotti F, Accame L, Lorenzoni
V, Frenkel J, Gattorno M, Quartier P,, Martini AAn in Silico Health economic
model applied to Cryopyrin Associated period syndromes (CAPS): cost effectiveness
of prevention effects of ultra-orphan drugs for rare diseases. ISPOR 18th Annual
European Congress, Milan, 7-11 November 2015.
5 of 8
6. Cavallo, F., Trieste, L., Esposito, R., Aquilano, M., Dario, P., Turchetti, G. Are
the elderly citizens ready for assisted living technologies? An Italian case Study.
ISPOR 18th Annual European Congress, Milan, 7-11 November 2015.
7. Trieste, L., Della Casa Alberighi O, Turchetti G, Pierotti F, Accame L, Lorenzoni
V, Frenkel J, Gattorno M, Quartier P,, Martini A. Cost-effectiveness analysis and
prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied
to Cryopyrin Associated Periodic Syndromes (CAPS). Poster accepted at ISSAID
2015: 8th International Congress of Familial Mediterranean Fever and Systemic
Autoinflammatory Diseases, 30 September - 3 October 2015, Dresden.
8. Della Casa Alberighi, Trieste, L., Accame L, Lorenzoni V, Pierotti F, Federici S,
Gattorno M, Quartier P, Duong Ngoc P, Cabrera R, Martini A, Turchetti G. The
RaDiCEA Project: Cost of illness (COI) analysis applied to Cryopyrin Associated
Periodic Syndromes (CAPS). Poster accepted at ISSAID 2015: 8th International
Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases.
30 September - 3 October 2015, Dresden.
9. Trieste, L. La valutazione economica della telemedicina. @ITIM2015, 15-th
National Congress on Telemedicine and medical information, 10-12 September,
Lamezia Terme (IT).
10. Trieste, L., Pagliai, T., Esposito, R., Cavallo, F., Dario, P., Turchetti, G. How
to design a business model for technology-driven innovations like robots. The case
of Robot-Era. 2015 R&D Management Conference. Pisa, 23-26 June 2015.
11. Trieste, L., Turchetti, G. Assessing the value of the use of diagnostic technology:
trade offs for GPs. 2015 R&D Management Conference. Pisa, 23-26 June 2015.
12. Trieste, L. Il thesaurus EUROVOC come patrimonio informativo di base per le
ontologie tematiche. OnLine Data Integration Network. WorkShop: CNR. Pisa,
March 24, 2015.
13. Trieste, L., Turchetti, G., Della Casa Alberighi, O. Obiettivi e strategie per
l’analisi farmacoeconomica nel Progetto RaDiCEA.
Conference on Autoinflammatory Disorder, ISEF Gaslini, Genoa, 4 March 2015.
14. Gialetti, S., Trieste, L., Pierotti, F., Turchetti, G., Silvestri, M., Della Casa
Alberighi, O. Comparison of Generic, Condition-Specific and Mapped Health State
Utility Values for Pediatric Asthma. ISPOR 17th Annual European Congress,
Amsterdam, 8-12 November 2014.
15. Pierotti, F. Trieste, L., Turchetti. G. Different Strategies for Latent TB assessment
in patients undergoing anti-TNF treatment: An economic model. ISPOR 17th
Annual European Congress, Amsterdam, 8-12 November.
16. Fusco, F., Trieste, L., Turchetti, G. 2013. Approaching 2014: Is Telemedicine
Assessed from The Social Perspective? A Brief 2013 Systematic Review. Sixth
International Conference on eHealth, Telemedicine, and Social Medicine, IARIA,
2014: 271-279.
17. Pierotti, F., Palla, I., Trieste, L., Turchetti, G. The definition of a new organizational,
technology-based, integrated home care model. Poster presented at the 26th
International CARS (computer assisted radiology and surgery) conference, Pisa,
June 27-30, 2012.
18. Trieste, L., Turchetti, G. 2010. Liberalizzazioni, struttura di mercato e strategie
di marketing: le tendenze nella distribuzione dei farmaci da banco. Italian Marketing
Society, VII annual meeting, Ancona, September 2008.
6 of 8
Other
contributes
1. Turchetti G., P. Gazzaniga, L. Trieste. 2012. Strumenti per favorire gli investimenti
e la competitività delle imprese. Produzione, ricerca e innovazione nel settore dei
dispositivi medici in Italia. Questioni aperte; 59-64.
2. Turchetti G., P. Gazzaniga, L. Trieste. 2012. Le start up. Produzione, ricerca e
innovazione nel settore dei dispositivi medici in Italia. Rapporto; 33-36.
3. Turchetti G., P. Gazzaniga, L. Trieste. 2012. Finanziamenti pubblici. Produzione,
ricerca e innovazione nel settore dei dispositivi medici in Italia. Questioni aperte;
N. 1; 51-56.
4. L. Trieste. 2006. Farmaci e distribuzione: gli scenari futuri, Scuola Superiore
Sant’Anna, Main Working Paper.
Work in
progress
Books
1. Turchetti, G., Pierotti, F., Trieste, L., Lorenzoni, V. 2016. Introduction to the
economic assessment in Healthcare.
2. Trieste, L., Lorenzoni, V., Turchetti, G. 2016. Methods and Models for the
Cost-effectiveness Analysis in Healthcare
3. Trieste, L. 2015. L’evoluzione della distribuzione del farmaco e dell’erogazione
dei servizi in farmacia. Un’analisi economica, storica, manageriale.
Articles
1. Fusco F., Trieste, L., Turchetti. 2014. A Systematic Literature Review On CostEffectiveness In Telemedicine: The Hidden Path For Telelecare Diffusion. SSSA,
IDM.
2. Turchetti, G., Cinquini, L., Trieste, L., Campanale, C., Tumino, E., Arena, A.
2013. Second step solutions for incomplete colonoscopy. Sensitivity, prevention,
and cost saving of ENDOTICS, SSSA, IDM.
3. Trieste, L., Turchetti, G. 2013. Scarcity, Constant Returns and Resource Allocation
in Health: the Inconsistencies of QALY as a measure of effectiveness. SSSA, IDM.
4. Trieste, L., Turchetti. 2013. G. The role of ultrasound in abdominal pain. Is it
time to transfer the technology to GPs? A model for assessing the change. SSSA.
MAIN Lab.
5. Fusco F., Trieste, L., Turchetti. 2013. G. Cost-effectiveness and diffusion of
telemedicine: A systematic review on hinders and potential solution for Telemedicine
adoption. SSSA. IDM.
6. Trieste, L., Turchetti, G. 2012. Using diagnostic technology: trade offs for GPs.
SSSA, Main Lab.
7. Trieste, L., Turchetti, L. G. 2012. Models of learning, probability updating and
the impact of diagnostic technology. SSSA, Main Lab.
8. Trieste, L., Turchetti, G, Geisler, E. 2013 The Columbus egg and the engineer
effects in innovation adoption: when technology and problems do not fit. SSSA,
IDM.
7 of 8
Editorial
activities and
reviewer
Reviewer for: PharmacoEconomics, Applied Health Economics and Health Policy,
Medical Research Archives, Journal of Rheumatology, Journal of Telemedicine and
Telecare.
Member of the Research Abstract Review Committee for the 2016 ISPOR 21st
Annual International Meeting, Washington, DC, USA.
Operative systems
Hardware and
Software Skills OX Mac, MSWindows
Computer Programs
MSOffice, LATEX, R, WinBugs, E-Views, STATA,
SPSS, TreeAge, Neural Connection, Answer Tree,
Protégé, NetLogo, OpenProj
8 of 8